Member Info for Dibs61

My research was based around the comments made by the expert porphyry geologist in the RNS dated 25th Feb which stated the following:

‘Mr Doug Menzies, Consulting Geologist and local expert in porphyry copper-gold deposits within the Lachlan Fold Belt said: "The extensive chalcopyrite-pyrrhotite mineralisation, potassic hydrothermal alteration, and associated geological features such as a transgressive phreatomagmatic breccia, suggest the Racecourse Prospect hosts a large fertile porphyry-related hydrothermal system."

I paid particular attention to the phrase ‘transgressive phreatomagmatic breccia’ because I had no idea what it meant. I have a lightly better idea now and it’s good, oh yes, it’s good.....

We should all be genuinely excited. I have been doing some more research on the geology they are experiencing. In the most recent RNS dated 5th Feb the company stated:

‘The drill rig will now be re-oriented and the third hole of the programme will aim to test the width and grade of the mineralisation higher in the deposit to assist in defining the 3-dimensional shape and orientation of the porphyry system.’

So now they have decided to drill higher up in the system. Would anyone care to hazard a guess why or what they are expecting to find? My research has made this apparent.

Actually he said ‘well in excess of £500m’ which is massively ahead of market expectations.

This should be moving towards £5 on back of these results.

mole man is correct. If you read the AAZ recent presentation, and all the related RNS’s for that matter it is quite clear JV is an entirely separate vehicle to Conroy corporate activities. Conroy will still have to fund itself for WC and it’s other activities.

This is dragging on way too long and the risk is growing that this will be ‘shelved’. I don’t think either company will want to cause the embarrassment to the other (or themselves) that they couldn’t do a deal so it will be deferred or some suchlike term. Not permanently cancelled but an ‘aspiration’ perhaps...

You need to read the recent AAZ presentation which is very clear there are fundamental unresolved issues.

bicurl that’s a loooong time! So for you I guess another 6 weeks is ok?

Trying to work out why SP still struggling. I think this might explain it:

RNS 2.2.2021 Issue of Equity

Xtract announces that it has received notice to exercise warrants over 2,000,000 ordinary shares of 0.02p each in the Company ("Ordinary Shares") at an exercise price of 1.85p per Ordinary Share. Accordingly, the Company has issued, 2,000,000 new Ordinary Shares in settlement of this exercise ("Warrant Exercise Shares").The Company has also agreed to settle a corporate creditor through the issuance 2,103,152 new ordinary shares at an issue price of 5.03p per ordinary share ("Settlement Shares").

The Warrant Exercise Shares and the Settlement Shares (together the "New Ordinary Shares") will rank pari passu with the existing Ordinary Shares and application is being made for in aggregate 4,103,152 New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence at 8.00 a.m. on 8 February 2021.

So we’ve got a creditor who’s accepted 2m shares in lieu of cash settlement. They are likely to want to monetise that payment. We’ve got 2m warrants issued at 1.85p. Why would you not take a large profit there?

So that’s another 4m shares to potentially churn through that only came onto the market yesterday. It’ll take more than a day or two for that to happen though of course if we get positive news in meantime that should speed it up.

Does anyone have an idea why SP is dropping today as gold/silver prices are up overnight and looking good right now. Seems a little odd? Results expected in early March which should be excellent.

Plus UBS apparently put out a note yesterday with price target 2300.

Looks pretty good to me. On the RNS dated 15th December PJ stated the following:

“Paul Johnson, Chief Executive Officer of Power Metal Resources commented: "With this announcement today Power Metal has now received over £1.2 million from warrant exercises since August 2020.

Today with the exercise monies received, the Company's working capital of cash and listed investments exceeded £2 million putting Power Metal Resources in a robust financial position as we approach the calendar year end.”

I have calculated that since the RNS dated 15th Dec they have collected a further £1,504,597 in warrant subscriptions.

That makes a current cash and cash equivalents total of over £3.5m less any monies paid for project funding and WC used since that date. In Paul’s recent interview I think he mentioned cash position was still robust and they intend to become self financing.

Good going when you consider the amount of dilution from warrants against the SP performance which has been tidy!

That said I am currently down here but don’t expect to be for too long.

Fowldzy - it’s not about PE ratios here. Not applicable because atm the company is not generating revenue and thus parotitis. We hope it will start to be over the course of the next few months and then perhaps we can start to calculate PE ratios if they are turning a profit. There has been plenty of information provided on this board if you track back a few pages. Otherwise it’s all about research, your research.

moonparty - this is not a bio it’s a diagnostics company. There’s quite a big difference you know.

CCAP have raised £460k in cash through warrant exercises in the past month.

I am becoming more convinced that what we are seeing is a rerating of the stock based on the market now believing this WILL receive FDA approval. If I'm right then approval is being priced in. The question is what valuation will the market give AGL prior to approval? Brokers and some investors alike are talking about £1.50-£2.00. I would say thats about right for now. However, there are a lot of other things going on at AGL which could provide catalysts over and above that figure so I would not assume that is a ceiling between now and say the middle of the year. Def not interested at all in trying to be clever and trading this stock. This is not a typical AIM stock, this is a quality proposition. NASDAQ listing later this year too.

Looks like we’re not finished with the placee churn yet. Combine that with the opportunity to trade out for now anticipating no significant news for the moment and I guess you get today’s result. Risky though. We know Colin likes to drop an RNS or three.

I do not think the market has cottoned onto the real implications behind todays announcement. The implications are HUGE. In simple terms that you can use Parsortix to tailor appropriate/correct treatment (personalised medicine) for NSCLC patients. And not waste large amounts of money on the wrong treatment.

Hi Serge1 - it is precisely because I AM level headed and keep a balanced view that I am concerned. Read this from the recent AAZ corporate presentation on 28th January 2021:

"If the joint venture can be concluded, significant profit opportunities will arise -

• JV negotiations ongoing with several issues unresolved but key points include:
• Various operational framework issues including “operatorship” and land acquisition
• A legal structure for the joint venture companies acceptable to both parties"

I had no idea from the recent interviews with both Prof Conroy AND the AAZ CEO that the 'issues' were this significant. I am very surprised that after many many months of negotiations the parties have NOT agreed upon "Operatorship". This is astonishing, and fundamental to the JV. That is not 'finishing touches' to the agreement. Plus 'a legal structure for the JV companies'. Again, astonished because I was under the clear impression that was all concluded and agreed, but according to AAZ (and I have no reason to disbelieve them) this fundamental aspect of the JV setup - not agreed!

So please do not accuse me of not being level headed. I have my head firmly screwed on thank you and i always keep an open mind about my investments. I suggest you should too if you wish to preserve your capital.

BJoffree - absolutely take your points and agree with you. However, I hope from the above explanation you can see now why I have reached this conclusion.

nm

And don’t reply to their threads with their name in the title. You are feeding the troll.

The news will continue to flow thick and fast....

Parsortix adding another string to its bow.

Yet more positive news this time in aiding the treatment of non small cell lung cancer.

This business is industry disruptive and it’s important to realise what that means.

Really like PJ and his business model. Very much aligned to shareholders. Very focused on just this one company and very enthusiastic. If this guy doesn’t succeed it won’t be for lack of trying that’s for sure. That said I am sure he will succeed. It’s a very impressive SP performance in the past year. Not having followed that closely I didn’t realise just how good it was.

If ever you were going to invest in a junior resource stock because of management this would be the one.

I agree with all that Diversified, with one exception. We are not ‘arguably’ ahead of the competition. We ARE ahead of all the competition. We have USP and will take a large chunk of the market. But by the time that happens we will have been bought by a Major for billions. Even £8 share would only put us at £1.8bn which, for the huge market grabbing potential is cheap.